Positive preclinical data for deoxymabs in vasculitis
Potential to use Deoxymabs to treat autoimmune diseases
Quarterly Activities Report and 4C | 31 December 2023
GMP Production of PAT-DX1 Next Quarter
Patrys Receives R&D Tax Incentive Refund
Data to be presented at leading brain cancer conference
Retirement of Non-Executive Director
Patrys FY23 Annual Report
Quarterly Activities Report and 4C | 30 June 2023
QUARTERLY ACTIVITIES REPORT & 4C | 31 March 2023
1
2
3
4
5
Next